Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-045915)

Filing Details

Accession Number:: 0001209191-17-045915
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-07-21 16:04:26
Reporting Period:: 2017-07-19

Filing Date:: 2017-07-21
Accepted Time:: 2017-07-21 16:04:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1662524	Akcea Therapeutics Inc.	AKCA	Pharmaceutical Preparations (2834)	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
874015	Ionis Pharmaceuticals Inc	2855 Gazelle Court Carlsbad CA 92010		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-07-19	28,884,540	$0.00	28,884,540	No	4	C	Direct
Common Stock	Acquisiton	2017-07-19	13,438,339	$0.00	42,322,879	No	4	J	Direct
Common Stock	Acquisiton	2017-07-19	3,125,000	$8.00	45,447,879	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	J	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2017-07-19	28,884,540	$0.00	28,884,540	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a one-for-one basis. The shares have no expiration date.
Shares issued in satisfaction of the Issuer's obligations to the Reporting Person pursuant to a line of credit.
The shares were purchased at the Issuer's initial public offering.